182 related articles for article (PubMed ID: 16357619)
1. Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Gonzalez-Suarez B; Guarner C; Villanueva C; Minana J; Soriano G; Gallego A; Sainz S; Torras X; Cusso X; Balanzo J
Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):49-55. PubMed ID: 16357619
[TBL] [Abstract][Full Text] [Related]
2. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Lo GH; Chen WC; Wang HM; Yu HC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
[TBL] [Abstract][Full Text] [Related]
5. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
Lo GH; Chen WC; Chen MH; Hsu PI; Lin CK; Tsai WL; Lai KH
Gastroenterology; 2002 Sep; 123(3):728-34. PubMed ID: 12198699
[TBL] [Abstract][Full Text] [Related]
6. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
Romero G; Kravetz D; Argonz J; Vulcano C; Suarez A; Fassio E; Dominguez N; Bosco A; Muñoz A; Salgado P; Terg R
Aliment Pharmacol Ther; 2006 Aug; 24(4):601-11. PubMed ID: 16827811
[TBL] [Abstract][Full Text] [Related]
7. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
Lo GH; Chen WC; Lin CK; Tsai WL; Chan HH; Chen TA; Yu HC; Hsu PI; Lai KH
Hepatology; 2008 Aug; 48(2):580-7. PubMed ID: 18666235
[TBL] [Abstract][Full Text] [Related]
8. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Bosch J
P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Sarin SK; Wadhawan M; Gupta R; Shahi H
Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
[TBL] [Abstract][Full Text] [Related]
10. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
Kravetz D
J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
[TBL] [Abstract][Full Text] [Related]
13. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
[TBL] [Abstract][Full Text] [Related]
14. [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Schepke M
Dtsch Med Wochenschr; 2009 Sep; 134(37):1823-7. PubMed ID: 19728251
[No Abstract] [Full Text] [Related]
15. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J
Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538
[TBL] [Abstract][Full Text] [Related]
16. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
García-Pagán JC; Villanueva C; Albillos A; Bañares R; Morillas R; Abraldes JG; Bosch J;
Gut; 2009 Aug; 58(8):1144-50. PubMed ID: 19218249
[TBL] [Abstract][Full Text] [Related]
17. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy for secondary prophylaxis of variceal rebleeding?
Maldonado D; Barkin JS
Am J Gastroenterol; 2002 Aug; 97(8):2134-6. PubMed ID: 12190191
[No Abstract] [Full Text] [Related]
19. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.
Lo GH; Chen WC; Chan HH; Tsai WL; Hsu PI; Lin CK; Chen TA; Lai KH
J Gastroenterol Hepatol; 2009 Jun; 24(6):982-7. PubMed ID: 19638080
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological therapy for portal hypertension: rationale and results.
Burroughs AK; Panagou E
Semin Gastrointest Dis; 1995 Jul; 6(3):148-64. PubMed ID: 7551972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
